Second Symposium of Novel Molecular Targets for Cancer Therapy
- 1 August 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 7 (S3) , 1-3
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Vascular Endothelial Growth Factor: Regulation in the Mouse Skin Carcinogenesis Model and Use in Antiangiogenesis Cancer TherapyThe Oncologist, 2002
- The Cell Cycle as a Target for Cancer Therapy: Basic and Clinical Findings with the Small Molecule Inhibitors Flavopiridol and UCN-01The Oncologist, 2002
- First Symposium of Novel Molecular Targets for Cancer TherapyThe Oncologist, 2001
- New molecular targets for anticancer therapyMolecular Medicine Today, 1998
- Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rateProceedings of the National Academy of Sciences, 1998
- Cancer Cell CyclesScience, 1996
- The retinoblastoma protein and cell cycle controlCell, 1995
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992
- Spontaneous Ha‐ras Gene Activation in Cultured Primary Murine Keratinocytes: Consequences of Ha‐ras Gene Activation in Malignant Conversion and Malignant ProgressionMolecular Carcinogenesis, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971